Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Merck Serono Targets Japan's Underdeveloped Fertility Market, Builds Line Extensions On Vital Products

This article was originally published in PharmAsia News

Executive Summary

TOKYO - The pharmaceutical market in Japan is the world's second-largest, but most large companies are pretty well saturated here. Many companies now tout growth projections in China, drawing the regional spotlight away from Japan. But Merck Serono is aggressively promoting its products in Japan, trying to make up for lost time
Advertisement

Related Content

Advertisement
UsernamePublicRestriction

Register

SC073676

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel